This inventor holds 1 USPTO granted patent. Top assignee: Hokuriku Pharmaceutical Co., Ltd.. Active years: 1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993
Title: Masakazu Kitayama: Innovator in Pharmaceutical Composition
Introduction
Masakazu Kitayama is a notable inventor based in Ohno, Japan. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative compositions that enhance the effectiveness of medications. His work is characterized by a focus on improving the disintegration and dispersion of pharmaceutical compounds in the digestive tract.
Latest Patents
Masakazu Kitayama holds 1 patent for a pharmaceutical composition comprising calcium polycarbophil. This composition is designed to be disintegrated in an acidic environment and includes calcium polycarbophil along with 1 to 80% by weight of a cellulose derivative, such as carboxymethylcellulose or low substituted hydroxypropylcellulose. The resulting pharmaceutical composition can be formulated as a tablet, capsule, or granules, making it useful as a bulk-forming laxative or an antidiarrheic agent. Its ability to disintegrate readily in the stomach allows for a complete dispersion of polycarbophil in the digestive tract, enhancing its therapeutic effects.
Career Highlights
Masakazu Kitayama is associated with Hokuriku Pharmaceutical Co., Ltd., where he has been instrumental in developing innovative pharmaceutical solutions. His expertise in the formulation of effective medications has contributed to the company's reputation in the pharmaceutical industry.
Collaborations
Throughout his career, Masakazu Kitayama has collaborated with esteemed colleagues, including Yasuo Ito and Hideo Kato. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in pharmaceutical research.
Conclusion
Masakazu Kitayama's contributions to pharmaceutical compositions demonstrate his commitment to advancing medical science. His innovative approach to drug formulation has the potential to improve patient outcomes significantly. His work continues to inspire future developments in the field of pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile